×
Back to Agenda
How to Avoid Shortages? Insights from the EU Executive Steering Group on Shortages – Learnings from the COVID-19 Pandemic
Session Chair(s)
Monica Dias, PharmD, PhD, MPharm, RPh
Head of Supply and Availability of Medicines and Devices, a.i., European Medicines Agency, Netherlands
The EU Steering Group on shortage coordinated urgent actions to prevent supply disruptions within the EU during the pandemic, including regulatory flexibilities and monitoring of shortages of medicines used for COVID-19 patients.
Learning Objective : Describe how shortages of medicines are coordinated in the EU/EEA, their root causes, and contingency measures to prevent or mitigate shortages; Discuss how the European Medicines Regulatory Network (EMRN) has stepped up its efforts to prevent or mitigate the impact of shortages of medicines during the COVID-19 pandemic.
Speaker(s)
Charlotte Roffiaen
European Policy Advisor , France Assos Santé, France
How to Avoid Shortages: Patients Point of View
Jan De Belie
Professional Affairs Advisor, Pharmaceutical Group of the European Union (PGEU), Belgium
Avoiding Shortages During COVID-19: Lessons Learned From Community Pharmacists
David Jauch, MBA
Director - Government Affairs and CSR, Fresenius Kabi Deutschland GmbH, Germany
Update
Have an account?